BusinessActinium Pharmaceuticals to Participate in the Oppenheimer & Co. Boston Oncology Insights Summit on August 16-17, 2017By Nasdaq OMXAug 9, 2017, 11:30 AM UTC
BusinessAptose Reports Results for the Second Quarter Ended June 30, 2017By Nasdaq OMXAug 8, 2017, 8:06 PM UTC
BusinessAnthony Stein, M.D., is Honored by the American Health Council for Best in MedicineBy Nasdaq OMXAug 7, 2017, 2:05 PM UTC
BusinessActinium Announces Closing of Public Offering of Common Stock and Warrants to Purchase Common StockBy Nasdaq OMXAug 2, 2017, 8:05 PM UTC
BusinessActinium Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common StockBy Nasdaq OMXJul 28, 2017, 1:10 PM UTC
BusinessActinium Announces Proposed Public Offering of Common Stock and Warrants to Purchase StockBy Nasdaq OMXJul 27, 2017, 8:06 PM UTC
BusinessActinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies on July 13, 2017 at 8:00 am ETBy Nasdaq OMXJul 13, 2017, 11:00 AM UTC
BusinessActinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies on July 13, 2017 at 8:00 am ETBy Nasdaq OMXJul 6, 2017, 11:30 AM UTC
